NCT03628300View on ClinicalTrials.gov

Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors

CompletedOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions

NeurotoxicitySepsisBeta LactamsTherapeutic Drug MonitoringCritical CareAcute Kidney Injury

All Listed Sponsors

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03628300 - Neurotoxicity Evaluation of Beta-lactams in Intensive Care Unit and Identification of the Risk Factors | Biotech Hunter | Biotech Hunter